These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6678863

  • 1. Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system.
    Cowan JD, Von Hoff DD, Clark GM.
    Invest New Drugs; 1983; 1(2):139-44. PubMed ID: 6678863
    [Abstract] [Full Text] [Related]

  • 2. Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.
    Drewinko B, Yang LY, Barlogie B, Trujillo JM.
    Cancer Res; 1983 Jun; 43(6):2648-53. PubMed ID: 6850582
    [Abstract] [Full Text] [Related]

  • 3. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
    Bowden GT, Roberts R, Alberts DS, Peng YM, Garcia D.
    Cancer Res; 1985 Oct; 45(10):4915-20. PubMed ID: 4027978
    [Abstract] [Full Text] [Related]

  • 4. Comparative cardiac oxygen radical metabolism by anthracycline antibiotics, mitoxantrone, bisantrene, 4'-(9-acridinylamino)-methanesulfon-m-anisidide, and neocarzinostatin.
    Doroshow JH, Davies KJ.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2935-9. PubMed ID: 6313012
    [Abstract] [Full Text] [Related]

  • 5. Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone.
    Lathan B, Von Hoff DD, Elslager E.
    Cancer Treat Rep; 1984 May 01; 68(5):733-8. PubMed ID: 6233003
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.
    Cowan JD, Neidhart J, McClure S, Coltman CA, Gumbart C, Martino S, Hutchins LF, Stephens RL, Vaughan CB, Osborne CK.
    J Natl Cancer Inst; 1991 Aug 07; 83(15):1077-84. PubMed ID: 1875415
    [Abstract] [Full Text] [Related]

  • 7. Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives.
    Bron D, Dodion P, Rozencweig M, Delforge A, Mattelaer MA, Kenis Y, Stryckmans P.
    Invest New Drugs; 1986 Aug 07; 4(1):11-6. PubMed ID: 3700036
    [Abstract] [Full Text] [Related]

  • 8. P-glycoprotein mediates profound resistance to bisantrene.
    Zhang XP, Ritke MK, Yalowich JC, Slovak ML, Ho JP, Collins KI, Annable T, Arceci RJ, Durr FE, Greenberger LM.
    Oncol Res; 1994 Aug 07; 6(7):291-301. PubMed ID: 7865904
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
    Cowan JD, Osborne CK, Neidhart JA, Von Hoff DD, Constanzi JJ, Vaughn CB.
    Invest New Drugs; 1985 Aug 07; 3(2):149-52. PubMed ID: 3894277
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.
    Alberts DS, Dorr RT, Wunz TP, Remers WA, Einspahr J, Liu R, Salmon SE.
    Anticancer Drugs; 1991 Feb 07; 2(1):69-77. PubMed ID: 1958855
    [Abstract] [Full Text] [Related]

  • 15. Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.
    Hill BT, Dennis LY, Li XT, Whelan RD.
    Cancer Chemother Pharmacol; 1985 Feb 07; 14(3):194-201. PubMed ID: 3858013
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
    Capranico G, Palumbo M, Tinelli S, Mabilia M, Pozzan A, Zunino F.
    J Mol Biol; 1994 Jan 28; 235(4):1218-30. PubMed ID: 8308885
    [Abstract] [Full Text] [Related]

  • 19. Activity of 4'-0-tetrahydropyranyladriamycin hydrochloride (THP-ADM) in a human tumor cloning system.
    Inoue K, Arakawa M, Miyamoto H, Ogawa M.
    Invest New Drugs; 1983 Jan 28; 1(4):271-5. PubMed ID: 6687222
    [Abstract] [Full Text] [Related]

  • 20. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I, Ohnoshi T, Hiraki S, Miyamoto H.
    Gan To Kagaku Ryoho; 1987 Mar 28; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.